Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00158171 · ClinicalTrials.gov registry record · Phase 2
Effectiveness of Various Smoking Cessation Therapies in Reducing Smoking in Adolescents - 1
A Phase 2 study, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 2
- Development phase
- 128
- Enrollment target
NCT00158171 is a Phase 2 study that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 128 participants.
The verdict
NCT00158171, a Phase 2 study, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 128 participants
- Enrollment target
Study Summary
Currently one in five high school students smokes. Smoking can harm adolescents well before they reach adulthood by causing a number of immediate, sometimes irreversible, health risks and problems. This study will compare the effectiveness of treatment with bupropion, a nicotine patch, or nicotine gum in supporting the reduction of smoking in adolescent smokers.
Interventions
- DRUG Nicotine patch
- DIETARY_SUPPLEMENT Folic Acid
- DRUG Nicotine Replacement Therapies
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2002-04 |
| Est. Completion | 2004-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00158171
The ClinicalTrials.gov registry entry for NCT00158171 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 128 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Nicotine patch is the first listed.
NCT00158171 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00158171 about?
NCT00158171 is a clinical study titled "Effectiveness of Various Smoking Cessation Therapies in Reducing Smoking in Adolescents - 1". Currently one in five high school students smokes. Smoking can harm adolescents well before they reach adulthood by causing a number of immediate, sometimes irreversible, health risks and problems. This study will compare the effectiveness of treatment with bupropion, a nicotine patch, or nicotine g...
What is the current status of trial NCT00158171?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 128 participants. The study started on 2002-04. Estimated completion is 2004-05.
What interventions are being tested in trial NCT00158171?
The interventions under investigation include: Nicotine patch (DRUG), Folic Acid (DIETARY_SUPPLEMENT), Nicotine Replacement Therapies (DRUG).
Who is sponsoring clinical trial NCT00158171?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.